Montenarh, D; Hopf, M; Warth, S; Maurer, HH; Schmidt, P; Ewald, AH. A simple extraction and LC-MS/MS approach for the screening and identification of over 100 analytes in eight different matrices: Detection of 130 analytes in eight biosamples using only one LC-MS/MS method. Drug Test. Anal., 1 Mar 2015, 7 (3), 214-240. 593 kB. https://doi.org/10.1002/dta.1657
Hermanns-Clausen, M; Kneisel, S; Hutter, M; Szabo, B; Auwärter, V. Acute intoxication by synthetic cannabinoids - Four case reports: Acute intoxication by synthetic cannabinoids - Four case reports. Drug Test. Anal., 1 Sep 2013, 5 (9-10), 790-794. 112 kB. https://doi.org/10.1002/dta.1483
Moosmann, B; Auwärter, V. Designer benzodiazepines: Another class of new psychoactive substances. In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 383-410. 497 kB. https://doi.org/10.1007/164_2018_154 #Midazolam
Currie, KS. Antianxiety Agents. In Burger's Medicinal Chemistry and Drug Discovery; Abraham, DJ, Ed., John Wiley & Sons, Inc., 15 Jan 2003; pp 525–597. 2.7 MB. https://doi.org/10.1002/0471266949.bmc102 #41
Urban, BW; Bleckwenn, M. Concepts and correlations relevant to general anaesthesia. Br. J. Anaesth., 1 Jul 2002, 89 (1), 3–16. 684 kB. https://doi.org/10.1093/bja/aef164 #Midazolam